Challenges in conducting clinical research studies in pregnant women.
Monique McKieverHeather FreyMaged M CostantinePublished in: Journal of pharmacokinetics and pharmacodynamics (2020)
Maternal mortality and morbidity continue to rise in the United States. Despite these trends there are limited novel interventions to investigate and improve these metrics, partly due to research protocol limitations which restrict participation of pregnant women. Inclusion of pregnant women in research studies is integral to the process of obtaining important information regarding the safety and efficacy of therapeutics or interventions to improve maternal health and pregnancy outcomes. While significant changes in research practices have resulted in an increase of female participants, there remains a paucity of research trials directly targeting pregnant and lactating women. This article provides an overview of issues surrounding inclusion of pregnant or breastfeeding women in research studies, and includes historical perspectives, navigating concerns over safety profile, considerations for appropriate development, and future perspectives.
Keyphrases
- pregnancy outcomes
- pregnant women
- physical activity
- case control
- healthcare
- public health
- primary care
- randomized controlled trial
- health information
- mental health
- preterm infants
- cardiovascular events
- risk factors
- coronary artery disease
- cardiovascular disease
- metabolic syndrome
- adipose tissue
- health promotion
- climate change
- birth weight
- weight loss